Global High Potency API CDMOs Market Size, Share, Key Growth Drivers, Opportunities and Developments by 2027
High potency active pharmaceutical ingredients (HPAPIs) are a class of pharmaceutical compounds which are characterized by their high pharmacological activity at low doses. These are typically drugs which are effective in small quantities, often measured in micrograms (µg) or even nanograms (ng). HPAPIs are used in the development and production of certain specialized medications, majorly in oncology and some other disease segments where precise dosing and minimal side effects are essential. HPAPI CDMOs are equipped with the expertise, facilities, and equipment needed to handle HPAPIs safely and efficiently, including their high potency, toxicity, and containment needs. These firms can handle many aspects of HPAPI manufacturing, including the process development, scale-up, and commercial production. Biologic HPAPIs and the Evolving Landscape of Drug Development The global pharmaceutical market has been experiencing an increasing demand for targeted therapies, mainly in markets such as...